Study directory

Bipolarity studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
102studies shown
Showing 85-96 of 102
Drug study icon
CompletedNCT04133233

Low Dose IL-2 Therapy in people with a Depressive Episode in the Course of a Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In France
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
France
Sponsor
Assistance Publique - Hôpitaux de Paris
Condition
Bipolarity, Depression
Behavioral study icon
CompletedNCT03630822

Comparative and Prospective Study Evaluating the Impact on the Care Path of an Editorial Program Accompanied by Advance Directives in Psychiatry (DAP) for People Suffering From Schizophrenia, Bipolarity type I or Schizoaffective Disorder

This study is completed in France. It focuses on schizophrenia.

In France
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, SchizophreniaBehavioralOver 18 Years
Countries
France
Sponsor
Assistance Publique Hopitaux De Marseille
Condition
Bipolarity, Schizophrenia
Drug study icon
CompletedNCT01914393

Pediatric Extension Study

This study is completed in the United States, in France, in Bulgaria, .... It focuses on Schizophrenia.

In France
Why is this study shown?

This study includes Bipolarity among several conditions.

Schizophrenia, Bipolarity, ...DrugFrom 6 Years to 17 Years
Countries
United States, France, Bulgaria, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Schizophrenia, Bipolarity, ...
Behavioral study icon
CompletedNCT04436757

Self and Body-esteem in Socio-professional Rehabilitation

This summary needs review. Please check the official study record and contact the research team for details.

In France
Why is this study shown?

This study includes Bipolarity among several conditions.

Depression, Schizophrenia, ...BehavioralFrom 18 Years to 65 Years
Countries
France
Sponsor
Hôpital le Vinatier
Condition
Depression, Schizophrenia, ...
Other study type icon
TerminatedNCT02765880

Time,Self and Spontaneous Mental Activities in people with Psychotic Disorders

This summary needs review. Please check the official study record and contact the research team for details.

In France
Why is this study shown?

This study includes Bipolarity among several conditions.

Schizophrenia, BipolarityOtherFrom 18 Years to 60 Years
Countries
France
Sponsor
University Hospital, Strasbourg, France
Condition
Schizophrenia, Bipolarity
Device study icon
Active Not RecruitingNCT07057024

Contribution of Virtual Reality Eye Tracking in the Identification of Schizophrenia, Bipolar and Depression

This observational study is following people with mental health conditions to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

Remote / online
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, Depression, ...OtherFrom 18 Years to 60 Years
Countries
France
Sponsor
Etablissement Public de Santé Barthélemy Durand
Condition
Bipolarity, Depression, ...
Drug study icon
CompletedEUCTR 2009-016667-11

A Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 and 200 mg/day) as Adjunctive Therapy in Adults With Major D...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In France
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrug
Countries
France, Bulgaria, Spain
Sponsor
Cephalon, Inc.
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT01485640

Lurasidone Extended Use Study

This summary needs review. Please check the official study record and contact the research team for details.

In France
Why is this study shown?

This study includes Bipolarity among several conditions.

Schizophrenia, BipolarityDrug
Countries
France, Canada, Colombia, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Schizophrenia, Bipolarity
Drug study icon
Not recruitingEUCTR 2009-016648-38

A 6-Month, Open-Label, Flexible-Dosage (150 to 200 mg/day) Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With ...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In France
Why is this study shown?

This study includes Bipolarity among several conditions.

Depression, BipolarityDrug
Countries
France, Bulgaria, Finland, ...
Sponsor
Cephalon, Inc.
Condition
Depression, Bipolarity
Drug study icon
Not recruitingEUCTR 2007-002551-17

Randomised, double-blind, parallel-group, placebo-controlled, and active referenced study of Lu AA34893 to evaluate the efficacy and safety of three doses Lu AA34893 and quetiapine versus placebo i...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In France
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrug
Countries
France, United Kingdom, Belgium, ...
Sponsor
H. Lundbeck a/s
Condition
Bipolarity, Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.